Please login to the form below

Not currently logged in
Email:
Password:

Merck and Co/MSD

This page shows the latest Merck and Co/MSD news and features for those working in and with pharma, biotech and healthcare.

Merck, Eisai’s Keytruda/Lenvima regimen scores full approval in endometrial cancer

Merck, Eisai’s Keytruda/Lenvima regimen scores full approval in endometrial cancer

Merck &Co – known as MSD outside the US and Canada – and Eisai have announced that their immunotherapy combination Keytruda plus Lenvima has been approved in the US to treat endometrial cancer. . ... Patients receiving Merck and Eisai’s treatment

Latest news

More from news
Approximately 0 fully matching, plus 68 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Merck & Co appoints Frank Clyburn as president, human health Merck & Co appoints Frank Clyburn as president, human health

    Merck &Co – known as MSD outside the US and Canada – has appointed Frank Clyburn (pictured above) as president, human health. ... Clyburn joined Merck &Co in 2008 and during his time with the company, he has had responsibility for various global

  • Merck KGaA’s Oschmann elected president of IFPMA Merck KGaA’s Oschmann elected president of IFPMA

    He takes over from Lilly’s John Lechleiter. Global pharma trade body the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has elected Merck KGaA's Stefan Oschmann as its new ... His pharma experience includes an 11-year

  • Merck KGaA shakes up pharma leadership Merck KGaA shakes up pharma leadership

    Johannes Baillou, chairman of the board of partners of Merck, said: “With today's management decisions we strengthen Merck's leadership team and prepare the ground for continuity to reach our ... Oschmann also joined Merck in 2011, having spent the

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Jet Off with Maloff Protect

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...